JP2010540619A5 - - Google Patents

Download PDF

Info

Publication number
JP2010540619A5
JP2010540619A5 JP2010527598A JP2010527598A JP2010540619A5 JP 2010540619 A5 JP2010540619 A5 JP 2010540619A5 JP 2010527598 A JP2010527598 A JP 2010527598A JP 2010527598 A JP2010527598 A JP 2010527598A JP 2010540619 A5 JP2010540619 A5 JP 2010540619A5
Authority
JP
Japan
Prior art keywords
hyaluronic acid
eye drop
tamarind seed
seed polysaccharide
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010527598A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010540619A (ja
JP5542674B2 (ja
Filing date
Publication date
Priority claimed from IT000510A external-priority patent/ITRM20070510A1/it
Application filed filed Critical
Publication of JP2010540619A publication Critical patent/JP2010540619A/ja
Publication of JP2010540619A5 publication Critical patent/JP2010540619A5/ja
Application granted granted Critical
Publication of JP5542674B2 publication Critical patent/JP5542674B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010527598A 2007-10-02 2008-10-02 タマリンド種子多糖およびヒアルロン酸に基づく点眼組成物 Active JP5542674B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITRM2007A000510 2007-10-02
IT000510A ITRM20070510A1 (it) 2007-10-02 2007-10-02 Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
PCT/IT2008/000626 WO2009044423A1 (en) 2007-10-02 2008-10-02 Ophthalmic compositions based on tamarind seed polysaccharide and hyaluronic acid

Publications (3)

Publication Number Publication Date
JP2010540619A JP2010540619A (ja) 2010-12-24
JP2010540619A5 true JP2010540619A5 (enExample) 2011-11-17
JP5542674B2 JP5542674B2 (ja) 2014-07-09

Family

ID=40314052

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010527598A Active JP5542674B2 (ja) 2007-10-02 2008-10-02 タマリンド種子多糖およびヒアルロン酸に基づく点眼組成物

Country Status (14)

Country Link
US (1) US8455462B2 (enExample)
EP (1) EP2197456B1 (enExample)
JP (1) JP5542674B2 (enExample)
KR (1) KR101570966B1 (enExample)
AT (1) ATE499106T1 (enExample)
CA (1) CA2701721C (enExample)
DE (1) DE602008005173D1 (enExample)
ES (1) ES2361529T3 (enExample)
IT (1) ITRM20070510A1 (enExample)
MX (1) MX2010003488A (enExample)
PL (1) PL2197456T3 (enExample)
PT (1) PT2197456E (enExample)
RU (1) RU2493855C2 (enExample)
WO (1) WO2009044423A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7726809B2 (en) * 2005-02-09 2010-06-01 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
IT1396607B1 (it) 2009-11-16 2012-12-14 Hmfra Hungary Ltd Liability Company Preparazioni oftalmiche a base di bdnf (brain-derived neurotrophic factor) e loro uso.
WO2011147767A1 (en) * 2010-05-24 2011-12-01 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of microbial infections
AU2011257388B2 (en) 2010-05-24 2016-10-13 Indena S.P.A. Tamarind seed polysaccharide for use in the treatment of inflammatory diseases
FR2963240B1 (fr) * 2010-07-28 2013-03-15 Horus Pharma Composition a usage topique sans conservateur comprenant de l'acide hyaluronique
IT1404145B1 (it) * 2010-12-27 2013-11-15 Altergon Sa Composizioni di acido ialuronico stabilizzate verso l'azione di degradazione del calore o degli enzimi
EP2883931A1 (en) * 2013-12-12 2015-06-17 Omya International AG Improved gel stability
ES2675305T3 (es) 2014-04-15 2018-07-10 Novintethical Pharma Sa Composiciones a base de xiloglucano y proteínas para el tratamiento de trastornos intestinales
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
EP3103438B1 (en) 2015-06-11 2018-11-14 Novintethical Pharma SA Topical nasal compositions containing xyloglucans for use as decongestans
SG10201913468YA (en) * 2015-07-13 2020-03-30 Tohoku Techno Arch Co Ltd Composition for optic nerve protection
AR108280A1 (es) * 2016-05-05 2018-08-08 Acraf Composición oftálmica que comprende una combinación sinérgica de glucógeno y ácido hialurónico o sal del mismo
IT201600108848A1 (it) * 2016-10-27 2018-04-27 Giuliani Spa Composizioni dermatologiche
WO2019025986A1 (en) * 2017-08-02 2019-02-07 Shilpa Medicare Limited OPHTHALMIC COMPOSITIONS OF CYCLOSPORINE
US11129862B2 (en) * 2017-08-30 2021-09-28 Johnson & Johnson Consumer Inc. Ophthalmic compositions
MX2021000665A (es) * 2018-07-18 2021-03-25 Atg 20 S R L Composicion que comprende glicirrina y usos cosmeticos y farmaceuticos de la misma.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL80298A (en) * 1986-10-14 1993-01-31 Res & Dev Co Ltd Eye drops
IT1283911B1 (it) * 1996-02-05 1998-05-07 Farmigea Spa Soluzioni oftalmiche viscosizzate con polisaccaridi della gomma di tamarindo
ES2252865T3 (es) * 1997-09-26 2006-05-16 Noven Pharmaceuticals, Inc. Composiciones bioadhesivas y metodos para la administracion topica de agentes activos.
CN1320880C (zh) * 1998-12-23 2007-06-13 伊迪亚股份公司 改进的体内局部无创伤用制剂
WO2005039619A1 (en) * 2003-10-03 2005-05-06 Allergan, Inc. Compositions and methods comprising prostaglandin-related compounds and trefoil factor family peptides for the treatment of glaucoma with reduced hyperemia
US7726809B2 (en) * 2005-02-09 2010-06-01 Safilens S.R.L. Contact lens, method for producing same, and pack for storage and maintenance of a contact lens
TWI393567B (zh) * 2005-03-31 2013-04-21 Bausch & Lomb 治療乾眼之組合物及相關之製造方法及使用方法

Similar Documents

Publication Publication Date Title
RU2010117173A (ru) Глазные композиции на основе полисахарида семян тамаринда и гиалуроновой кислоты
PH12019550088A1 (en) Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery
CA2535364A1 (en) Hyaluronic acid nanoparticles
WO2019075263A3 (en) Methods and compositions for topical delivery
JP2010538011A5 (enExample)
AR070824A1 (es) Suspensiones para inyeccion intravitrea de triamcinolona acetonido de baja viscosidad, altamente floculadas
CA2637753A1 (en) Fabric care compositions comprising cationic starch
MX2010010726A (es) Composicion de estilizado de cabello.
BRPI0711620A2 (pt) misturas poliméricas de polissacarídeos aniônicos e catiônicos e uso destas
AR074541A1 (es) Composiciones desinfectantes de plata naturales
JP2011507976A5 (enExample)
WO2010149363A3 (en) Pharmaceutical composition comprising rotigotine salts (acid or na), especially for iontophoresis
JP2009535342A5 (enExample)
UA107570C2 (xx) Безспиртовий водний розчин, що містить пропранолол
AR089962A1 (es) Composiciones farmaceuticas oftalmicas y metodos para su elaboracion y uso
WO2008136034A3 (en) Ophthalmic compositions for the treatment of ocular hypertension and glaucoma
WO2010116382A3 (en) Stable pharmaceutical compositions of diclofenac
CA2677715C (en) Use of chitosans to increase nail growth rate
WO2008148573A3 (de) Arzeimittel mit einer wirkstoffkombination enthaltend pantothensäure oder deren derivate zur behandlung von allergischen symptomen
JP2013518051A5 (enExample)
BRPI0518191A (pt) métodos e composições para reduzir a toxicidade de um composto farmacêutico
JP2015504860A5 (enExample)
JP2015528515A5 (enExample)
JP2016522257A5 (enExample)
AR062939A1 (es) Agente para el tratamiento y/o prevencion del tizon